• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维狭窄性炎症性肠病的流行病学。

Epidemiology of fibrostenosing inflammatory bowel disease.

机构信息

Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Science, Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

J Dig Dis. 2020 Jun;21(6):332-335. doi: 10.1111/1751-2980.12853.

DOI:10.1111/1751-2980.12853
PMID:32105396
Abstract

Fibrostenosis occurs in both Crohn's disease (CD) and ulcerative colitis (UC). Up to 21% of patients with CD present with strictures at diagnosis, while the rate of stenosis varies from 1% to 11% in UC. Despite the increasing use of immunomodulators and biologics in treatment, there has been no decrease in the rate of progression from inflammatory to complicated disease phenotypes (either stricturing or penetrating). The presence of stenosis is an independent risk factor for surgery in patients with CD, who are at a risk of postoperative recurrence at a rate of up to 55% at 10 years after surgery. Patients with inflammatory bowel disease (IBD) strictures are at risk of malignant transformation. Thus, surveillance colonoscopy should be offered to this group of patients. Several risk factors for the development of stricture have been identified. In CD, patients aged less than 40-years old, with perianal disease at diagnosis, who need steroids at the first flare up or have ileal disease are at the risk of developing strictures; while in UC, patients with extensive colitis and long-standing disease are at risk. Recently, microbiota signatures have also been identified as markers for stricture development. The presence of Ruminococcus spp. is associated with the development of stricture in pediatric patients with CD. In this review, we highlight the epidemiology, risk factors and natural history of fibrostenosing IBD.

摘要

纤维狭窄症发生于克罗恩病(CD)和溃疡性结肠炎(UC)中。高达 21%的 CD 患者在诊断时即出现狭窄,而 UC 的狭窄发生率为 1%至 11%不等。尽管在治疗中越来越多地使用免疫调节剂和生物制剂,但炎症向复杂疾病表型(狭窄或穿透)的进展率并没有降低。狭窄的存在是 CD 患者手术的独立危险因素,这些患者术后复发的风险高达 55%,术后 10 年复发率为 55%。患有炎症性肠病(IBD)狭窄的患者有恶性转化的风险。因此,应向这组患者提供结肠镜监测。已经确定了几种发展为狭窄的危险因素。在 CD 中,年龄小于 40 岁、诊断时伴有肛周疾病、首次发作时需要类固醇治疗或患有回肠疾病的患者有发展为狭窄的风险;而在 UC 中,广泛性结肠炎和疾病持续时间长的患者有风险。最近,微生物组特征也被确定为狭窄发展的标志物。在患有 CD 的儿科患者中,直肠真杆菌的存在与狭窄的发展有关。在这篇综述中,我们重点介绍了纤维狭窄性 IBD 的流行病学、危险因素和自然病史。

相似文献

1
Epidemiology of fibrostenosing inflammatory bowel disease.纤维狭窄性炎症性肠病的流行病学。
J Dig Dis. 2020 Jun;21(6):332-335. doi: 10.1111/1751-2980.12853.
2
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.循环中的cathelicidin水平与溃疡性结肠炎的黏膜疾病活动、克罗恩病的肠道狭窄风险以及炎症性肠病的临床预后相关。
BMC Gastroenterol. 2017 May 12;17(1):63. doi: 10.1186/s12876-017-0619-4.
3
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.儿童及青年溃疡性结肠炎与克罗恩病的鉴别:北美儿科胃肠病学、肝病学和营养学会及美国克罗恩病和结肠炎基金会工作组报告
J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3.
4
Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.儿童炎症性肠病5年随访的自然病史:来自儿童炎症性肠病登记处数据的回顾性分析
J Pediatr Gastroenterol Nutr. 2008 May;46(5):539-45. doi: 10.1097/MPG.0b013e3181596efd.
5
Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.平滑肌增生/肥大是克罗恩病纤维狭窄性肠狭窄最显著的组织学改变:使用新的组织学分级方案进行半定量分析。
J Crohns Colitis. 2017 Jan;11(1):92-104. doi: 10.1093/ecco-jcc/jjw126. Epub 2016 Jun 30.
6
High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.高循环 Elafin 水平与克罗恩病相关的肠道狭窄有关。
PLoS One. 2020 Apr 14;15(4):e0231796. doi: 10.1371/journal.pone.0231796. eCollection 2020.
7
Surgical treatment of intestinal stricture in inflammatory bowel disease.炎症性肠病的肠狭窄的外科治疗。
J Dig Dis. 2020 Jun;21(6):355-359. doi: 10.1111/1751-2980.12880. Epub 2020 Jun 18.
8
Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.儿童克罗恩病狭窄和穿透性并发症的发生率。
Inflamm Bowel Dis. 2010 Apr;16(4):638-44. doi: 10.1002/ibd.21099.
9
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.炎症性肠病:诊断程序使用中的争议
Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24.
10
Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.结直肠癌合并炎症性肠病:基于三十年经验的克罗恩病和溃疡性结肠炎的异同。
Ann Surg. 2010 Aug;252(2):330-5. doi: 10.1097/SLA.0b013e3181e61e69.

引用本文的文献

1
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn's Disease.微生物群在预测克罗恩病纤维性狭窄中的突出作用。
J Inflamm Res. 2025 Feb 5;18:1413-1423. doi: 10.2147/JIR.S480473. eCollection 2025.
2
Endoscopic radial incision and cutting using balloon-assisted enteroscopy for small intestinal stenosis related to Crohn's disease: a pilot study.使用气囊辅助小肠镜对克罗恩病相关小肠狭窄进行内镜下径向切开和切割:一项初步研究。
Intest Res. 2025 Jul;23(3):302-308. doi: 10.5217/ir.2024.00143. Epub 2025 Jan 21.
3
Expanding Options for Endoscopic Therapy of Strictures in Patients with Inflammatory Bowel Disease: Is Stricturotomy the Best?
炎症性肠病患者狭窄内镜治疗的扩展选择:狭窄切开术是最佳选择吗?
Dig Dis Sci. 2025 Jan;70(1):19-22. doi: 10.1007/s10620-024-08726-w. Epub 2024 Dec 13.
4
Safety and effectiveness of additional triamcinolone acetonide with endoscopic radial incision and cutting for benign stenosis of the lower gastrointestinal tract: A pilot study.内镜下放射状切开及切除联合曲安奈德治疗下消化道良性狭窄的安全性和有效性:一项初步研究。
DEN Open. 2024 Sep 3;5(1):e70002. doi: 10.1002/deo2.70002. eCollection 2025 Apr.
5
Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model.肠道微生物群在克罗恩病发病机制中的作用:来自小鼠模型粪便微生物群移植的启示。
World J Gastroenterol. 2024 Aug 21;30(31):3689-3704. doi: 10.3748/wjg.v30.i31.3689.
6
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease.用于模拟炎症性肠病纤维化的患者来源肠类器官的表征。
Inflamm Res. 2024 Aug;73(8):1359-1370. doi: 10.1007/s00011-024-01901-9. Epub 2024 Jun 6.
7
Ultrasound in Pediatric Inflammatory Bowel Disease-A Review of the State of the Art and Future Perspectives.小儿炎症性肠病中的超声——现状与未来展望综述
Children (Basel). 2024 Jan 25;11(2):156. doi: 10.3390/children11020156.
8
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?遗传和表观遗传调控在炎症性肠病肠道纤维化中的作用:是一个下行过程还是程序性后果?
Genes (Basel). 2023 May 27;14(6):1167. doi: 10.3390/genes14061167.
9
Fuc-S-A New Ultrasonic Degraded Sulfated α-l-Fucooligosaccharide-Alleviates DSS-Inflicted Colitis through Reshaping Gut Microbiota and Modulating Host-Microbe Tryptophan Metabolism.Fuc-S-A 一种新型超声降解硫酸化 α-l-岩藻低聚糖,通过重塑肠道微生物群和调节宿主-微生物色氨酸代谢来缓解 DSS 诱导的结肠炎。
Mar Drugs. 2022 Dec 25;21(1):16. doi: 10.3390/md21010016.
10
Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix.炎症性肠病相关肠道共生菌降解细胞外基质成分。
mBio. 2022 Dec 20;13(6):e0220122. doi: 10.1128/mbio.02201-22. Epub 2022 Nov 29.